AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE921.20-8.7 (-0.94 %)
PREV CLOSE ( ) 929.90
OPEN PRICE ( ) 930.15
BID PRICE (QTY) 921.25 (132)
OFFER PRICE (QTY) 921.70 (47)
VOLUME 21045
TODAY'S LOW / HIGH ( )920.40 937.95
52 WK LOW / HIGH ( )281.15 996.65
NSE922.00-8 (-0.86 %)
PREV CLOSE( ) 930.00
OPEN PRICE ( ) 935.00
BID PRICE (QTY) 921.60 (1)
OFFER PRICE (QTY) 922.00 (16)
VOLUME 995518
TODAY'S LOW / HIGH( ) 920.00 938.00
52 WK LOW / HIGH ( )288.85 996.85
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
24Dec Announcement under Regulation 30 (LOD
We enclose a copy of the Press Release that is being issued by the Compa..
24Dec Aurobindo Pharma, Tata Communications
Aurobindo Pharma has entered into an Exclusive License Agreement with CO..
24Dec Aurobindo Pharma enters into exclusive
Aurobindo Pharma has entered into an Exclusive License Agreement with CO..
24Dec Aurobindo Pharma gains on entering int
Aurobindo Pharma is currently trading at Rs. 897.95, up by 8.05 points o..
11Dec Announcement under Regulation 30 (LOD
We enclose a copy of the Press Release that is being issued by the Compa..
Financials
Rs. in Millions
QTR Sep 20 ANNUAL 20
Net Profit8015.418727.4
Gross Profit 11292 23777
Operating Profit 12557.629437.6
Net Sales 45243.4132664.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Procter&Gamble Healt (BSE)
 7040.00 (1.62%)
M.Cap (Rs. in Cr)11842.58
Solara Active Pharma (BSE)
 1320.00 (5.82%)
M.Cap (Rs. in Cr)4736.14
Torrent Pharma (BSE)
 2781.95 (2.18%)
M.Cap (Rs. in Cr)47208.39
Abbott India (BSE)
 14447.95 (0.31%)
M.Cap (Rs. in Cr)30885.86
Fredun Pharma (BSE)
 463.80 (8.35%)
M.Cap (Rs. in Cr)183.92
Shareholding Pattern
PROMOTERS 51.94%
NON-INSTITUTION 10.47%
MUTUAL FUNDS/UTI 9.94%
FI/BANKS/INSURANCE 0.21%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Sanjay Jadli, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances

For Lodge the grievances click on https://scores.gov.in

Click/visit on SEBI Complaints Redress System (SCORES) for Procedure for filing of complaints on SCORES and benefits.

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.